Arabic Arabic English English French French German German
dark

Autolus Announces Appointment of Edgar Braendle, M.D., Ph.D., as Chief Development Officer

Autolus Therapeutics plc, a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, announced the appointment of Edgar Braendle M.D., Ph.D., as chief development officer. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

White House Enlists Social Media Giants to Suppress Vaccine ‘Misinformation’

Next Post

Lexaria Completes Successful Antiviral Drug Molecular Characterization Study With Canada’s National Research Council

Related Posts
Total
0
Share